{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:14:15Z","timestamp":1788930855274,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.neuropharm.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T05:02:00Z","timestamp":1395810120000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA\/2J mice: I. Effects of D2\/D3 and D2 dopamine receptor selective compounds"],"prefix":"10.1016","volume":"83","author":[{"given":"Claudia","family":"Rangel-Barajas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maninder","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5098-8024","authenticated-orcid":false,"given":"Suwanna","family":"Vangveravong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Luedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.03.003_bib1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuropharm.2011.05.023","article-title":"Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors","volume":"61","author":"Albizu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(89)90178-7","article-title":"Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI","volume":"161","author":"Arnt","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2014.03.003_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0028-3908(77)90117-4","article-title":"\u201cWet-dog\u201d shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity","volume":"16","author":"Bedard","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib6","first-page":"605","article-title":"Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble","volume":"401","author":"Borroto-Escuela","year":"2010","journal-title":"Communications"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1073858412444466","article-title":"Tic disorders: what happen in the basal ganglia","volume":"19","author":"Bronfeld","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neubiorev.2012.09.010","article-title":"Pharmacological animal models of tourette syndrome","volume":"37","author":"Bronfeld","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study","volume":"62","author":"Bruggeman","year":"2001","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-010-1784-0","article-title":"The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen","volume":"209","author":"Canal","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib12","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Chen","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib13","unstructured":"Clarke, W. P., Berg, K. A., Gould, G., & Frazer, A. 2001. Characterization of 5-HT(1A,B) and 5-HT(2A,C) serotonin receptor binding. Curr. Protoc. Pharmacol. Chapter 1, Unit1.23."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A\u00a0possible correlation between drug- induced hallucinations in man and a behavioural response in mice","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0091-3057(94)00340-8","article-title":"Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI","volume":"50","author":"Darmani","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0079-6123(08)00905-9","article-title":"Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment","volume":"172","author":"de Almeida","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(00)02062-X","article-title":"Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area","volume":"864","author":"Doherty","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00213-011-2207-6","article-title":"Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL\/6N mice","volume":"215","author":"Douherty","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","article-title":"Similarities in the pharmacology of spontaneous and DOI-induced head shakes suggest 5-HT2A receptors are active under physiological conditions","volume":"128","author":"Dursun","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","article-title":"Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice","volume":"335","author":"Fantegrossi","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib23","first-page":"235","article-title":"Serotonin and Tourette's syndrome: movements such as head-shakes and wet-dog shakes may model human tics","volume":"85","author":"Handley","year":"1992","journal-title":"Adv. Biosci."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cn300138m","article-title":"Animal models of serotonergic psychedelics","volume":"4","author":"Hanks","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib25","first-page":"245","article-title":"Cerebral 5-HT2A receptor binding is increased in patients with tourette's syndrome","volume":"10","author":"Haugbol","year":"2007","journal-title":"Int. J. Neuropsychopharmacol.\/Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP)"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib26","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","article-title":"Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with tourette syndrome","volume":"102","author":"Kalanithi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. Am."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.23401","article-title":"Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?","volume":"26","author":"Karimi","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1994.tb14808.x","article-title":"In\u00a0vivo properties of SB 200646A, a 5-HT2C\/2B receptor antagonist","volume":"111","author":"Kennett","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)36843-0","article-title":"Pharmacological characterization of in\u00a0vivo properties of putative mixed 5-HT1A agonist\/5-HT2A\/2C antagonist anxiolytics. Drug discrimination and behavioral observation studies in rats","volume":"282","author":"Kleven","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1098-2396(20001215)38:4<438::AID-SYN9>3.0.CO;2-5","article-title":"Characterization of 125I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors","volume":"38","author":"Luedtke","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib31","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/cn300142q","article-title":"Pharmacological studies of D2 receptor selective compounds SV 293 and SV-III-130s","volume":"3","author":"Luedtke","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib32","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbamcr.2010.08.010","article-title":"Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors","volume":"1803","author":"Lukasiewicz","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","article-title":"Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group","volume":"111","author":"Nocjar","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/exnr.2002.8009","article-title":"Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models","volume":"177","author":"Oh","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2010.08.018","article-title":"L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V\/VI and increased GABA release in the substantia nigra reticulata","volume":"41","author":"Rangel-Barajas","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)09485-6","article-title":"DOI induced head twitches in the rat are mediated by 5-HT2A receptors","volume":"273","author":"Schreiber","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn3469","article-title":"Corticostriatal connectivity and its role in disease","volume":"14","author":"Shepherd","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-2952(95)02122-1","article-title":"Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities","volume":"51","author":"Sleight","year":"1996","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.21809","article-title":"Extrastriatal dopaminergic dysfunction in tourette syndrome","volume":"67","author":"Steeves","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bmc.2005.09.008","article-title":"Identification and pharmacologic characterization of D2 dopamine receptor selective antagonists","volume":"14","author":"Vangveravong","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib42","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.bmc.2011.04.021","article-title":"Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound","volume":"19","author":"Vangveravong","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in tourette syndrome: clues from an in\u00a0vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacol. : Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.003_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cortex.2012.08.020","article-title":"Towards a primate model of Gilles de la Tourette Syndrome: anatomo-behaviuoral correlation of disorders induced by striatal dysfunction","volume":"49","author":"Worbe","year":"2013","journal-title":"Cortex"},{"key":"10.1016\/j.neuropharm.2014.03.003_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-2999(75)90278-2","article-title":"Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice","volume":"32","author":"Yamamoto","year":"1975","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:48:13Z","timestamp":1746161293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":45,"alternative-id":["S0028390814000884"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA\/2J mice: I. Effects of D2\/D3 and D2 dopamine receptor selective compounds","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}